Loading…

The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia

The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP). This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of emergency medicine 2020-09, Vol.38 (9), p.1796-1801
Main Authors: Avci, Sema, Perincek, Gokhan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123
cites cdi_FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123
container_end_page 1801
container_issue 9
container_start_page 1796
container_title The American journal of emergency medicine
container_volume 38
creator Avci, Sema
Perincek, Gokhan
description The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP). This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics, comorbidities, arterial blood gas, serum electrolytes, liver-renal functions, complete blood count, NLR, PLR, CRP, CAR, procalcitonin, A-a O2 gradient, expected A-a O2 and A-a O2 difference were evaluated. PSI and CURB-65 scores were classified as follow: a) PSI low risk (I-III) and moderate-high risk (IV-V) groups; b) CURB-65; low risk (0–2) and high risk (3–5) groups. The survival rates of the PSI class (I-III) were significantly higher than the ones of the PSI class (IV-V) (92.1% vs. 62.9%, respectively). The percentage of survivors of the CURB-65 score (0–2) group (81.9%) was higher than the survivors of CURB-65 score (3–5) group (27.8%). Creatinine, BUN, uric acid, phosphorus, RDW, CRP, CAR, procalcitonin, lactate, A-a 02 gradient, expected A-a 02 and A-a 02 difference were significantly higher and basophil was lower in non-survivors. A-a O2 gradient (AUC 0.78), A-a O2 difference (AUC 0.74) and albumin (AUC 0.80) showed highest 30-day mortality prediction. NLR (AUC 0.58) and PLR (AUC 0.55) showed lowest 30-day mortality estimation. Procalcitonin (AUC 0.65), PSI class (AUC 0.81) and PSI score (AUC 0.86) indicated statistically significant higher 30-day mortality prediction. A-a O2 gradient, A-a O2 difference and albumin are potent predictors of 30-day mortality in CAP patients in the ED.
doi_str_mv 10.1016/j.ajem.2020.05.048
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2430095168</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735675720303958</els_id><sourcerecordid>2449741468</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoMoOK7-AU8BLx7sNpXu9Ad4kcWPhQUv6znUJtWatrszVjIDg3_ejCMIHvZUUPW8Rb31CvESVA0KurdzjTOttVZa1crUqh0eiR2YRlcD9PBY7FTfmKrrTf9UPEtpVgqgNe1O_Lr7ThKXI8UFuULOxAEX-Y3RB9ryG7nf6LDGLaBMdCzDfJLJRaYkcfMybNOC64o58kmuyD-Ik8xR7pl8cFk2qvJYJpEzLmdt2P5tfC6eTLgkevG3XomvHz_cXX-ubr98url-f1u5poNcDS0BDj2OZMbBeNJag1Go7o0G7wZDE9yT6QhpGk1X-n0HnsZ-GBtPCnRzJV5f9u45_jxQynYNydGy4EbxkKxuG6VGA91Q0Ff_oXM88FauK1Q79i20fyh9oRzHlJgmu-dQ3J8sKHvOw872nIc952GVsSWPInp3EVGxegzENrnyYlcexeSy9TE8JP8NV6OVWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2449741468</pqid></control><display><type>article</type><title>The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Avci, Sema ; Perincek, Gokhan</creator><creatorcontrib>Avci, Sema ; Perincek, Gokhan</creatorcontrib><description>The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP). This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics, comorbidities, arterial blood gas, serum electrolytes, liver-renal functions, complete blood count, NLR, PLR, CRP, CAR, procalcitonin, A-a O2 gradient, expected A-a O2 and A-a O2 difference were evaluated. PSI and CURB-65 scores were classified as follow: a) PSI low risk (I-III) and moderate-high risk (IV-V) groups; b) CURB-65; low risk (0–2) and high risk (3–5) groups. The survival rates of the PSI class (I-III) were significantly higher than the ones of the PSI class (IV-V) (92.1% vs. 62.9%, respectively). The percentage of survivors of the CURB-65 score (0–2) group (81.9%) was higher than the survivors of CURB-65 score (3–5) group (27.8%). Creatinine, BUN, uric acid, phosphorus, RDW, CRP, CAR, procalcitonin, lactate, A-a 02 gradient, expected A-a 02 and A-a 02 difference were significantly higher and basophil was lower in non-survivors. A-a O2 gradient (AUC 0.78), A-a O2 difference (AUC 0.74) and albumin (AUC 0.80) showed highest 30-day mortality prediction. NLR (AUC 0.58) and PLR (AUC 0.55) showed lowest 30-day mortality estimation. Procalcitonin (AUC 0.65), PSI class (AUC 0.81) and PSI score (AUC 0.86) indicated statistically significant higher 30-day mortality prediction. A-a O2 gradient, A-a O2 difference and albumin are potent predictors of 30-day mortality in CAP patients in the ED.</description><identifier>ISSN: 0735-6757</identifier><identifier>EISSN: 1532-8171</identifier><identifier>DOI: 10.1016/j.ajem.2020.05.048</identifier><language>eng</language><publisher>Philadelphia: Elsevier Inc</publisher><subject>Accuracy ; Albumin ; Alveolar-arterial oxygen gradient ; Alveoli ; Antibiotics ; Blood ; Blood platelets ; Cardiovascular disease ; Chronic illnesses ; Community-acquired pneumonia ; Creatinine ; Demography ; Emergency medical care ; Homeless people ; Independent sample ; Infections ; Inflammation ; Laboratories ; Lactic acid ; Medical prognosis ; Mortality ; Mortality risk ; Normal distribution ; Patients ; Phosphorus ; Pneumonia ; Procalcitonin ; Statistical analysis ; Survival ; Tuberculosis ; Uric acid</subject><ispartof>The American journal of emergency medicine, 2020-09, Vol.38 (9), p.1796-1801</ispartof><rights>2020 Elsevier Inc.</rights><rights>2020. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123</citedby><cites>FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Avci, Sema</creatorcontrib><creatorcontrib>Perincek, Gokhan</creatorcontrib><title>The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia</title><title>The American journal of emergency medicine</title><description>The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP). This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics, comorbidities, arterial blood gas, serum electrolytes, liver-renal functions, complete blood count, NLR, PLR, CRP, CAR, procalcitonin, A-a O2 gradient, expected A-a O2 and A-a O2 difference were evaluated. PSI and CURB-65 scores were classified as follow: a) PSI low risk (I-III) and moderate-high risk (IV-V) groups; b) CURB-65; low risk (0–2) and high risk (3–5) groups. The survival rates of the PSI class (I-III) were significantly higher than the ones of the PSI class (IV-V) (92.1% vs. 62.9%, respectively). The percentage of survivors of the CURB-65 score (0–2) group (81.9%) was higher than the survivors of CURB-65 score (3–5) group (27.8%). Creatinine, BUN, uric acid, phosphorus, RDW, CRP, CAR, procalcitonin, lactate, A-a 02 gradient, expected A-a 02 and A-a 02 difference were significantly higher and basophil was lower in non-survivors. A-a O2 gradient (AUC 0.78), A-a O2 difference (AUC 0.74) and albumin (AUC 0.80) showed highest 30-day mortality prediction. NLR (AUC 0.58) and PLR (AUC 0.55) showed lowest 30-day mortality estimation. Procalcitonin (AUC 0.65), PSI class (AUC 0.81) and PSI score (AUC 0.86) indicated statistically significant higher 30-day mortality prediction. A-a O2 gradient, A-a O2 difference and albumin are potent predictors of 30-day mortality in CAP patients in the ED.</description><subject>Accuracy</subject><subject>Albumin</subject><subject>Alveolar-arterial oxygen gradient</subject><subject>Alveoli</subject><subject>Antibiotics</subject><subject>Blood</subject><subject>Blood platelets</subject><subject>Cardiovascular disease</subject><subject>Chronic illnesses</subject><subject>Community-acquired pneumonia</subject><subject>Creatinine</subject><subject>Demography</subject><subject>Emergency medical care</subject><subject>Homeless people</subject><subject>Independent sample</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Laboratories</subject><subject>Lactic acid</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Mortality risk</subject><subject>Normal distribution</subject><subject>Patients</subject><subject>Phosphorus</subject><subject>Pneumonia</subject><subject>Procalcitonin</subject><subject>Statistical analysis</subject><subject>Survival</subject><subject>Tuberculosis</subject><subject>Uric acid</subject><issn>0735-6757</issn><issn>1532-8171</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kU2LFDEQhoMoOK7-AU8BLx7sNpXu9Ad4kcWPhQUv6znUJtWatrszVjIDg3_ejCMIHvZUUPW8Rb31CvESVA0KurdzjTOttVZa1crUqh0eiR2YRlcD9PBY7FTfmKrrTf9UPEtpVgqgNe1O_Lr7ThKXI8UFuULOxAEX-Y3RB9ryG7nf6LDGLaBMdCzDfJLJRaYkcfMybNOC64o58kmuyD-Ik8xR7pl8cFk2qvJYJpEzLmdt2P5tfC6eTLgkevG3XomvHz_cXX-ubr98url-f1u5poNcDS0BDj2OZMbBeNJag1Go7o0G7wZDE9yT6QhpGk1X-n0HnsZ-GBtPCnRzJV5f9u45_jxQynYNydGy4EbxkKxuG6VGA91Q0Ff_oXM88FauK1Q79i20fyh9oRzHlJgmu-dQ3J8sKHvOw872nIc952GVsSWPInp3EVGxegzENrnyYlcexeSy9TE8JP8NV6OVWQ</recordid><startdate>202009</startdate><enddate>202009</enddate><creator>Avci, Sema</creator><creator>Perincek, Gokhan</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>202009</creationdate><title>The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia</title><author>Avci, Sema ; Perincek, Gokhan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Accuracy</topic><topic>Albumin</topic><topic>Alveolar-arterial oxygen gradient</topic><topic>Alveoli</topic><topic>Antibiotics</topic><topic>Blood</topic><topic>Blood platelets</topic><topic>Cardiovascular disease</topic><topic>Chronic illnesses</topic><topic>Community-acquired pneumonia</topic><topic>Creatinine</topic><topic>Demography</topic><topic>Emergency medical care</topic><topic>Homeless people</topic><topic>Independent sample</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Laboratories</topic><topic>Lactic acid</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Mortality risk</topic><topic>Normal distribution</topic><topic>Patients</topic><topic>Phosphorus</topic><topic>Pneumonia</topic><topic>Procalcitonin</topic><topic>Statistical analysis</topic><topic>Survival</topic><topic>Tuberculosis</topic><topic>Uric acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Avci, Sema</creatorcontrib><creatorcontrib>Perincek, Gokhan</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of emergency medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Avci, Sema</au><au>Perincek, Gokhan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia</atitle><jtitle>The American journal of emergency medicine</jtitle><date>2020-09</date><risdate>2020</risdate><volume>38</volume><issue>9</issue><spage>1796</spage><epage>1801</epage><pages>1796-1801</pages><issn>0735-6757</issn><eissn>1532-8171</eissn><abstract>The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP). This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics, comorbidities, arterial blood gas, serum electrolytes, liver-renal functions, complete blood count, NLR, PLR, CRP, CAR, procalcitonin, A-a O2 gradient, expected A-a O2 and A-a O2 difference were evaluated. PSI and CURB-65 scores were classified as follow: a) PSI low risk (I-III) and moderate-high risk (IV-V) groups; b) CURB-65; low risk (0–2) and high risk (3–5) groups. The survival rates of the PSI class (I-III) were significantly higher than the ones of the PSI class (IV-V) (92.1% vs. 62.9%, respectively). The percentage of survivors of the CURB-65 score (0–2) group (81.9%) was higher than the survivors of CURB-65 score (3–5) group (27.8%). Creatinine, BUN, uric acid, phosphorus, RDW, CRP, CAR, procalcitonin, lactate, A-a 02 gradient, expected A-a 02 and A-a 02 difference were significantly higher and basophil was lower in non-survivors. A-a O2 gradient (AUC 0.78), A-a O2 difference (AUC 0.74) and albumin (AUC 0.80) showed highest 30-day mortality prediction. NLR (AUC 0.58) and PLR (AUC 0.55) showed lowest 30-day mortality estimation. Procalcitonin (AUC 0.65), PSI class (AUC 0.81) and PSI score (AUC 0.86) indicated statistically significant higher 30-day mortality prediction. A-a O2 gradient, A-a O2 difference and albumin are potent predictors of 30-day mortality in CAP patients in the ED.</abstract><cop>Philadelphia</cop><pub>Elsevier Inc</pub><doi>10.1016/j.ajem.2020.05.048</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0735-6757
ispartof The American journal of emergency medicine, 2020-09, Vol.38 (9), p.1796-1801
issn 0735-6757
1532-8171
language eng
recordid cdi_proquest_miscellaneous_2430095168
source ScienceDirect Freedom Collection 2022-2024
subjects Accuracy
Albumin
Alveolar-arterial oxygen gradient
Alveoli
Antibiotics
Blood
Blood platelets
Cardiovascular disease
Chronic illnesses
Community-acquired pneumonia
Creatinine
Demography
Emergency medical care
Homeless people
Independent sample
Infections
Inflammation
Laboratories
Lactic acid
Medical prognosis
Mortality
Mortality risk
Normal distribution
Patients
Phosphorus
Pneumonia
Procalcitonin
Statistical analysis
Survival
Tuberculosis
Uric acid
title The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T22%3A51%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20alveolar-arterial%20gradient,%20pneumonia%20severity%20scores%20and%20inflammatory%20markers%20to%20predict%2030-day%20mortality%20in%20pneumonia&rft.jtitle=The%20American%20journal%20of%20emergency%20medicine&rft.au=Avci,%20Sema&rft.date=2020-09&rft.volume=38&rft.issue=9&rft.spage=1796&rft.epage=1801&rft.pages=1796-1801&rft.issn=0735-6757&rft.eissn=1532-8171&rft_id=info:doi/10.1016/j.ajem.2020.05.048&rft_dat=%3Cproquest_cross%3E2449741468%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c361t-84e1a87a9e5985de222150a0b521dc85ef1be56eaef956a0b761de97893de0123%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2449741468&rft_id=info:pmid/&rfr_iscdi=true